Abstract
Quantum dots (QDs) have rapidly emerged as an attractive alternative to conventional organic fluorophores in a variety of biological imaging applications. Their improved photostability allows for long-term dynamic imaging of cellular processes and their narrow, size-tunable emission permits unprecedented multiplexing capabilities. Additionally, the inherent brightness of core/shell QDs, with quantum yields capable of exceeding 85%, provides increased sensitivity for both diagnostic screening and single molecule tracking applications. To date, the primary focus of research in this field has been directed towards modifying the surface chemistries of the QDs to introduce biological specificity while, at the same time, limiting nonspecific cellular interactions. As such, biomolecules such as antibodies, peptides, streptavidin and biotin have all been conjugated to QDs and been used to demonstrate specific labeling of cellular targets. Additionally, polyethylene glycol (PEG) modification of the QD surface has been shown to limit nonspecific interactions. The use of small molecule QD-conjugates has also been demonstrated as an effective means for targeted labeling of membrane associated receptors. This approach introduces specificity via ligand-receptor interactions, resulting in a highly modular system which is easily modified to interrogate a wide variety of cellular targets. This article provides a comprehensive review of the current status of QD imaging applications in biological systems with a particular emphasis on the design and application of small molecule nanoconjugates.
Keywords: Quantum dots, fluorescent imaging, biological application, surface modification
Current Nanoscience
Title: Fluorescent Imaging Applications of Quantum Dot Probes
Volume: 3 Issue: 4
Author(s): Michael R. Warnement, Ian D. Tomlinson and Sandra J. Rosenthal
Affiliation:
Keywords: Quantum dots, fluorescent imaging, biological application, surface modification
Abstract: Quantum dots (QDs) have rapidly emerged as an attractive alternative to conventional organic fluorophores in a variety of biological imaging applications. Their improved photostability allows for long-term dynamic imaging of cellular processes and their narrow, size-tunable emission permits unprecedented multiplexing capabilities. Additionally, the inherent brightness of core/shell QDs, with quantum yields capable of exceeding 85%, provides increased sensitivity for both diagnostic screening and single molecule tracking applications. To date, the primary focus of research in this field has been directed towards modifying the surface chemistries of the QDs to introduce biological specificity while, at the same time, limiting nonspecific cellular interactions. As such, biomolecules such as antibodies, peptides, streptavidin and biotin have all been conjugated to QDs and been used to demonstrate specific labeling of cellular targets. Additionally, polyethylene glycol (PEG) modification of the QD surface has been shown to limit nonspecific interactions. The use of small molecule QD-conjugates has also been demonstrated as an effective means for targeted labeling of membrane associated receptors. This approach introduces specificity via ligand-receptor interactions, resulting in a highly modular system which is easily modified to interrogate a wide variety of cellular targets. This article provides a comprehensive review of the current status of QD imaging applications in biological systems with a particular emphasis on the design and application of small molecule nanoconjugates.
Export Options
About this article
Cite this article as:
Warnement R. Michael, Tomlinson D. Ian and Rosenthal J. Sandra, Fluorescent Imaging Applications of Quantum Dot Probes, Current Nanoscience 2007; 3 (4) . https://dx.doi.org/10.2174/157341307782418595
DOI https://dx.doi.org/10.2174/157341307782418595 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Current Pharmaceutical Design Small Molecule Drugs and Targeted Therapy for Melanoma: Current Strategies and Future Directions
Current Medicinal Chemistry New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design Translating Enzymology into Metabolic Regulation: The Case of the 2- Oxoglutarate Dehydrogenase Multienzyme Complex
Current Chemical Biology A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century
Current Medicinal Chemistry Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia
Current Cancer Therapy Reviews Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
Current Pharmaceutical Design FLIM-FRET for Cancer Applications
Current Molecular Imaging (Discontinued) Discovery of New Cardiovascular Hormones for the Treatment of Congestive Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Clopidogrel, Aspirin and Proton Pump Inhibition after Percutaneous Valve Implants: An Update
Current Pharmaceutical Design Medical Implants as Delivery Platforms for Tissue Engineering and Regenerative Medicine Applications
Current Tissue Engineering (Discontinued) Dendrimers and the Double Helix - From DNA Binding Towards Gene Therapy
Current Topics in Medicinal Chemistry Antiinflammatory Activity of Melatonin in Central Nervous System
Current Neuropharmacology The Clinical Relevance of Advanced Glycation Endproducts (AGE) and Recent Developments in Pharmaceutics to Reduce AGE Accumulation
Current Medicinal Chemistry Harnessing the Power of Light to Treat Staphylococcal Infections Focusing on MRSA
Current Pharmaceutical Design New Molecular Targets in the Treatment of NSCLC
Current Pharmaceutical Design Marine Peptides for Preventing Metabolic Syndrome
Current Protein & Peptide Science Treating Nonthyroidal Illness Syndrome in the Critically Ill Patient: Still a Matter of Controversy
Current Drug Targets Current Progress of Lipid Analysis in Metabolic Diseases by Mass Spectrometry Methods
Current Medicinal Chemistry Rheumatological Manifestations in Diabetes Mellitus
Current Diabetes Reviews